[1]蒋苏宁,陈 莉.2018年~2019年某医院细菌耐药监测情况分析[J].医学信息,2021,34(15):156-158.[doi:10.3969/j.issn.1006-1959.2021.15.043]
　JIANG Su-ning,CHEN Li.Analysis of the Surveillance of Bacterial Resistance in A Hospital from 2018 to 2019[J].Medical Information,2021,34(15):156-158.[doi:10.3969/j.issn.1006-1959.2021.15.043]
点击复制

2018年~2019年某医院细菌耐药监测情况分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年15期
页码:
156-158
栏目:
调查分析
出版日期:
2021-08-01

文章信息/Info

Title:
Analysis of the Surveillance of Bacterial Resistance in A Hospital from 2018 to 2019
文章编号:
1006-1959（2021）15-0156-03
作者:
蒋苏宁; 陈 莉
（南京医科大学附属江宁医院药学部检验科，江苏 南京 211100）
Author(s):
JIANG Su-ning; CHEN Li
(Department of Laboratory Medicine,Ministry of Pharmacy,Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing 211100,Jiangsu,China)
关键词:
大肠埃希菌; 耐药监测; 氨苄西林; 复方新诺明; 药敏试验
Keywords:
Escherichia coli; Drug resistance monitoring; Ampicillin; Compound trimethoprim; Drug susceptibility test
分类号:
R446.5
DOI:
10.3969/j.issn.1006-1959.2021.15.043
文献标志码:
A
摘要:
目的 分析2018年~2019年某医院细菌耐药监测情况。方法 回顾性分析某医院2018年~2019年大肠埃希菌的耐药监测情况。结果 2018年共检出标本10,039株，其中痰标本2066株、尿液标本1797株、分泌物标本1699株、血标本972株、脓液标本604株、其他标本2901株。2018年某医院大肠埃希杆菌对头孢唑啉、氨苄西林、氨苄西林/舒巴坦、复方新诺明以及头孢噻肟的耐药率均在50%以上。2019年共检出标本14,027株，其中痰标本2996株、尿液标本2622株、分泌物标本2399株、血标本1344株、脓液标本840株、其他标本3826株。2019年某医院大肠埃希杆菌对头孢唑林、氨苄西林、氨苄西林/舒巴坦、复方新诺明的耐药率均在50%以上。结论 2018年~2019年某医院大肠埃希菌对头孢唑啉、氨苄西林、氨苄西林/舒巴坦以及复方新诺明的耐药率均较高于50%，临床中应结合药敏试验的结果，合理用药，保证治疗的有效性。
Abstract:
Objective To analyze the surveillance of bacterial resistance in a hospital from 2018 to 2019.Methods A retrospective analysis of the drug resistance surveillance of Escherichia coli in a hospital from 2018 to 2019.Results A total of 10,039 specimens were detected in 2018, including 2066 sputum specimens, 1797 urine specimens, 1699 secretions specimens, 972 blood specimens, 604 pus specimens, and 2901 other specimens.In 2018, the resistance rate of Escherichia coli in a hospital to cefazolin, ampicillin, ampicillin/sulbactam, compound trimethoprim and cefotaxime were all above 50%.A total of 14,027 specimens were detected in 2019, including 2996 sputum specimens, 2622 urine specimens, 2399 secretions specimens, 1344 blood specimens, 840 pus specimens, and 3826 other specimens.In 2019, the resistance rate of Escherichia coli in a hospital to cefazolin, ampicillin, ampicillin/sulbactam, and compound trimethoprim was more than 50%.Conclusion From 2018 to 2019, the resistance rate of Escherichia coli in a hospital to cefazolin, ampicillin, ampicillin/sulbactam and compound trimethoprim was higher than 50%.The results of drug susceptibility tests should be combined in clinical practice to use drugs rationally to ensure the effectiveness of treatment.

参考文献/References:

[1]吴湜,胡付品,蒋晓飞,等.2019年上海市三级医院细菌耐药监测[J].中国感染与化疗杂志,2021,21(1):1-10. [2]陈琳.某院血流感染病原菌分布及耐药性分析[J].医学信息,2020,33(10):150-152. [3]郑永贵,胡付品,朱德妹,等.2019年上海市二级医院细菌耐药监测[J].中国感染与化疗杂志,2021,21(1):11-20. [4]于瑞峰,郑晓琳,陈跃峰.91例急性咽峡炎患儿咽拭子标本的细菌培养及耐药性分析[J].首都食品与医药,2021,28(1):85-86. [5]Vaz-Moreira I,Varela AR,Pereira TV,et al.Multidrug Resistance in Quinolone-Resistant Gram-Negative Bacteria Isolated from Hospital Effluent and the Municipal Wastewater Treatment Plant[J].Microb Drug Resist,2016,22(2):155-163. [6]胡付品,郭燕,朱德妹,等.2018年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2020,20(1):1-10. [7]陈艳,林瑞,陈竹,等.2012至2018年某院肝硬化并自发性细菌性腹膜炎的病原学及耐药性分析[J].肝脏,2020,25(2):166-169. [8]Rudelli BA,Giglio PN,Carvalho VCD,et al.Bacteria drug resistance profile affects knee and hip periprosthetic joint infection outcome with debridement,antibiotics and implant retention[J].BMC Musculoskelet Disord,2020,21(1):574. [9]陆迪雅,许磊,马兰,等.小儿急性细菌性痢疾的病原菌分布特征及耐药性分析[J].传染病信息,2020,33(2):176-178,182. [10]周娟娟,杨俊梅,高凯杰,等.2018年河南省儿童医院细菌耐药性监测[J].中国感染与化疗杂志,2020,20(2):202-208. [11]陈娟,罗敏,李小荣,等.某医院儿科常见病原菌的耐药性及其与抗菌药物应用的相关性[J].西北药学杂志,2020,35(3):440-444. [12]李曙光,廖康,苏丹虹,等.2018年中国11所教学医院院内感染常见病原菌分布和耐药性[J].中华医学杂志,2020,100(47):3775-3783. [13]王维钧,舒高林,彭华,等.北京市昌平区感染性腹泻标本常见病原菌谱分析[J].实用预防医学,2019,26(10):128-131. [14]Dharmaraja AT.Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria[J].J Med Chem,2017,60(8):3221-3240. [15]马琼,李轶,王山梅,等.2018年河南省细菌耐药性监测[J].中国感染与化疗杂志,2020,20(1):67-75. [16]范蓉,武智聪,梁翠娟,等.革兰阴性杆菌产超广谱β-内酰胺酶(ESBLs)的检出率及其与细菌耐药性的关系[J].河北医学,2020,26(3):522-525. [17]张雪艳.118例糖尿病伴尿路感染患者清洁中段尿标本中细菌培养结果及其对抗菌药物的耐药性探究[J].抗感染药学,2020,17(4):532-535. [18]游义琴,王晶晶,王雪梅,等.2018年度某三甲综合医院常见多重耐药菌的科室分布特点及耐药性分析[J].国际检验医学杂志,2020(5):548-553. [19]丁锋,赵爱学.891例中段尿培养阳性标本感染病原学特点及药敏分析[J].检验医学与临床,2021,18(1):112-115. [20]马淑贞,张红旭,刘广全,等.我院抗菌药物实行分级管理后使用情况分析[J].现代生物医学进展,2015,15(20):3930-3932,3936.

相似文献/References:

[1]钱菲菲,周 易.尿路感染诊断治疗中临床微生物检验的病原菌结果分析[J].医学信息,2022,35(23):159.[doi:10.3969/j.issn.1006-1959.2022.23.035]
　QIAN Fei-fei,ZHOU Yi.Analysis of Pathogenic Bacteria Results of Clinical Microbiological Examination in the Diagnosis and Treatment of Urinary Tract Infection[J].Medical Information,2022,35(15):159.[doi:10.3969/j.issn.1006-1959.2022.23.035]
[2]魏长斌.头孢哌酮钠舒巴坦钠对糖尿病合并尿路感染的疗效及安全性分析[J].医学信息,2021,34(14):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]
　WEI Chang-bin.Analysis of the Efficacy and Safety of Cefoperazone Sodium and Sulbactam Sodium on Diabetes Complicated with Urinary Tract Infection[J].Medical Information,2021,34(15):151.[doi:10.3969/j.issn.1006-1959.2021.14.042]

更新日期/Last Update: 1900-01-01